Comparison of intravenous versus oral busulfan on the prognosis of paediatric patients with acute leukaemia undergoing haematopoietic stem cell transplantation

被引：0
|
作者：
Hamidieh, A. [1 ]
Behfar, M. [1 ]
Tayebi, S. [1 ]
Jalali, A. [1 ]
Aliabadi, L. Sharifi [1 ]
Hosseini, A. [1 ]
Basirpanah, S. [1 ]
Ghavamzadeh, A. [1 ]
机构：
[1] Univ Tehran Med Sci, Tehran, Iran
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [21] Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation
    Takama, H
    Tanaka, H
    Nakashima, D
    Ueda, R
    Takaue, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 (04) : 345 - 351
  • [22] Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
    Lu Bai
    Yong-zhan Zhang
    Chen-hua Yan
    Yu Wang
    Lan-ping Xu
    Xiao-hui Zhang
    Le-ping Zhang
    Xiao-jun Huang
    Yi-fei Cheng
    BMC Cancer, 22
  • [23] Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
    Bai, Lu
    Zhang, Yong-zhan
    Yan, Chen-hua
    Wang, Yu
    Xu, Lan-ping
    Zhang, Xiao-hui
    Zhang, Le-ping
    Huang, Xiao-jun
    Cheng, Yi-fei
    BMC CANCER, 2022, 22 (01)
  • [24] Autologous haematopoietic cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Mousavi, A.
    Khatami, F.
    Jalili, M.
    Babhadiashar, N.
    Gaffari, F.
    Alimogaddam, K.
    Iravani, M.
    Bahar, B.
    Jahani, M.
    Khodabandelu, A.
    Baibordi, E.
    Gavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S314 - S314
  • [25] Comparison of Intravenous and Oral Busulfan in Allogeneic Hematopoietic Stem Cells Transplantation in Acute Leukemias
    Valencia Carlo, V. A.
    Valero Saldana, L. M.
    Alfaro, M. A.
    Acosta Maldonado, B. L.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S444 - S444
  • [26] ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION USING INTRAVENOUS BUSULFAN IN MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMEN IN ACUTE LEUKEMIA PATIENTS. A COMPARISON ANALYSIS WITH ORAL BUSULFAN
    Sampol, A.
    Gutierrez, A.
    Ballester, C.
    Gual, C.
    Canaro, M.
    Novo, A.
    Galmes, A.
    Morey, M.
    Duran, M. A.
    Lo Rizzo, L.
    Besalduch, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S314 - S314
  • [27] Higher incidence of hypertension with intravenous busulfan compared to oral busulfan in thalassaemic children who underwent haematopoietic stem cell transplantation
    Tayfun, F.
    Baytan, B.
    Ozdemir, G. N.
    Akcan, M.
    Uygun, V.
    Karasu, G.
    Yesilipek, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S186 - S186
  • [28] Early allogeneic haematopoietic stem cell transplantation in acute lymphoblastic leukaemia patients
    Ghavamzadeh, A.
    Alimoghaddam, K.
    Mousavi, S. A.
    Iravani, M.
    Bahar, B.
    Ghaffari, F.
    Jalali, A.
    Jahani, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S97 - S97
  • [29] Busulfan in intravenous formulation in hematopoietic stem cell transplantation in paediatric age
    Prete, A.
    Rondelli, R.
    Luksch, R.
    Fagioli, F.
    Ripaldi, M.
    Favre, C.
    Di Bartolomeo, E.
    Lanino, E.
    Ziino, O.
    Messina, C.
    Rovelli, A.
    Caselli, D.
    Pession, A.
    Locatelli, F.
    HEMATOLOGY REPORTS, 2010, 2 (01)
  • [30] BODY MASS INDEX AND SURVIVAL OF PAEDIATRIC PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Fisher, R.
    Shaw, P.
    Kalra, M.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 171 - 171
12345